Month: February 2021

Six women reflect on their period experiences and journeys to self-advocacy in new video seriesVideo stories and additional information about “Voices of Periods” now available on femaleforwardtogether.comRED BANK, N.J. and BASEL, Switzerland, Feb. 16, 2021 (GLOBE NEWSWIRE) — HealthyWomen, the nation’s leading independent, nonprofit health information source for women, and Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today launched “Voices of Periods,” a storytelling initiative to elevate conversations about menstrual health by sharing diverse, personal stories of the real-life impact of menstrual stigma.“I’m so grateful to these remarkable women for stepping up to fight the stigma around menstruation, one personal narrative at a time,” said Beth Battaglino, RN-C, Chief Executive...

Nes-Ziona, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd., (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company targeting diseased macrophages in patients with sepsis, COVID-19 and solid tumors, today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,927,343 covering AllocetraTM, the company’s immunotherapy product candidate.  The new patent is expected to provide added intellectual property protection for methods of treating autoimmune and inflammatory diseases comprising gout, inflammatory bowel disease, Crohn’s disease, ulcerative colitis and graft versus host disease (GvHD).Oren Hershkovitz, PhD, CEO of Enlivex, stated, “We are pleased with this new patent allowance. While we are focusing our clinical development efforts at this stage...

SAN FRANCISCO, Feb. 16, 2021 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release its financial results for its second quarter of fiscal year 2021 ended January 30, 2021 after market close on Monday, March 8, 2021 followed by a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss Stitch Fix’s financial results and outlook. The call will be hosted by Katrina Lake, founder and CEO, Elizabeth Spaulding, President, and Dan Jedda, CFO. A live webcast will be accessible on the investor relations section of the Stitch Fix website at https://investors.stitchfix.com. The call can also be accessed domestically at (800) 458-4121 and internationally at (323) 794-2093, passcode 9716592.A telephonic replay will be available through Monday, March 15, 2021 at (888)...

CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, and Joe Mara, CFO, will participate in a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18, 2021, at 3:00p.m. Eastern Time.A live webcast of the event will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.com.About Vericel CorporationVericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an...

Located Pre-Security, Terminal C, Exclusively Used by United AirlinesExpansion Follows August 2020 Opening of XpresCheck location in Terminal BNEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) —  XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced in collaboration with United Airlines, the opening of its second XpresCheck testing facility at Newark Liberty International Airport.XpresCheck’s pop-up testing facility is located in the United Airlines’ Terminal C baggage claim area, pre-security. It will host four separate testing rooms with an anticipated capacity to administer over 300 tests per day. COVID-19 testing options will include the Rapid Molecular COVID-19 Test and the Polymerase Chain Reaction (PCR) Test.Doug Satzman, XpresSpa CEO, said, “We are thrilled to be opening...

RICHLAND, Wash., Feb. 16, 2021 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Lisa Lauer has been appointed Vice President, Business Development.CEO Lori Woods says Lauer’s appointment marks another important step forward for the Company, “Lisa Lauer brings deep industry experience and market knowledge to the Company. Lisa’s particular expertise in technologies used alone or in combination with immunotherapy for the treatment of cancer make her a perfect fit for Isoray. We believe Lisa will be an important addition to our team as we continue to pursue our strategic plan for growth opportunities in our core prostate business as well as in the treatment of other cancers.”Lisa Lauer brings more than 27 years of valuable expertise across...